M&T Bank’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.67M | Buy |
8,203
+335
| +4% | +$109K | 0.01% | 535 |
|
2025
Q1 | $2.12M | Sell |
7,868
-740
| -9% | -$200K | 0.01% | 593 |
|
2024
Q4 | $2.03M | Sell |
8,608
-37
| -0.4% | -$8.7K | 0.01% | 672 |
|
2024
Q3 | $2.38M | Buy |
8,645
+206
| +2% | +$56.7K | 0.01% | 620 |
|
2024
Q2 | $2.05M | Buy |
8,439
+2,013
| +31% | +$489K | 0.01% | 647 |
|
2024
Q1 | $960K | Sell |
6,426
-369
| -5% | -$55.2K | ﹤0.01% | 895 |
|
2023
Q4 | $1.3M | Sell |
6,795
-179
| -3% | -$34.3K | ﹤0.01% | 784 |
|
2023
Q3 | $1.24M | Buy |
6,974
+124
| +2% | +$22K | ﹤0.01% | 770 |
|
2023
Q2 | $1.3M | Sell |
6,850
-20
| -0.3% | -$3.8K | ﹤0.01% | 777 |
|
2023
Q1 | $1.38M | Buy |
6,870
+661
| +11% | +$132K | 0.01% | 752 |
|
2022
Q4 | $1.48M | Sell |
6,209
-423
| -6% | -$101K | 0.01% | 711 |
|
2022
Q3 | $1.33M | Buy |
6,632
+2,089
| +46% | +$418K | 0.01% | 726 |
|
2022
Q2 | $662K | Sell |
4,543
-119
| -3% | -$17.3K | ﹤0.01% | 905 |
|
2022
Q1 | $763K | Buy |
4,662
+1,075
| +30% | +$176K | ﹤0.01% | 841 |
|
2021
Q4 | $608K | Buy |
3,587
+15
| +0.4% | +$2.54K | ﹤0.01% | 941 |
|
2021
Q3 | $674K | Buy |
3,572
+15
| +0.4% | +$2.83K | ﹤0.01% | 876 |
|
2021
Q2 | $604K | Sell |
3,557
-120
| -3% | -$20.4K | ﹤0.01% | 940 |
|
2021
Q1 | $519K | Sell |
3,677
-130
| -3% | -$18.3K | ﹤0.01% | 980 |
|
2020
Q4 | $495K | Sell |
3,807
-99
| -3% | -$12.9K | ﹤0.01% | 1070 |
|
2020
Q3 | $569K | Sell |
3,906
-313
| -7% | -$45.6K | ﹤0.01% | 917 |
|
2020
Q2 | $626K | Buy |
4,219
+536
| +15% | +$79.5K | ﹤0.01% | 855 |
|
2020
Q1 | $402K | Sell |
3,683
-438
| -11% | -$47.8K | ﹤0.01% | 1001 |
|
2019
Q4 | $475K | Sell |
4,121
-712
| -15% | -$82.1K | ﹤0.01% | 871 |
|
2019
Q3 | $388K | Buy |
4,833
+157
| +3% | +$12.6K | ﹤0.01% | 1065 |
|
2019
Q2 | $339K | Sell |
4,676
-625
| -12% | -$45.3K | ﹤0.01% | 1158 |
|
2019
Q1 | $495K | Sell |
5,301
-4
| -0.1% | -$374 | ﹤0.01% | 969 |
|
2018
Q4 | $387K | Buy |
5,305
+188
| +4% | +$13.7K | ﹤0.01% | 1011 |
|
2018
Q3 | $448K | Buy |
5,117
+381
| +8% | +$33.4K | ﹤0.01% | 1044 |
|
2018
Q2 | $466K | Buy |
4,736
+523
| +12% | +$51.5K | ﹤0.01% | 1032 |
|
2018
Q1 | $502K | Buy |
4,213
+103
| +3% | +$12.3K | ﹤0.01% | 999 |
|
2017
Q4 | $522K | Buy |
4,110
+50
| +1% | +$6.35K | ﹤0.01% | 985 |
|
2017
Q3 | $477K | Sell |
4,060
-70
| -2% | -$8.22K | ﹤0.01% | 1002 |
|
2017
Q2 | $331K | Buy |
+4,130
| New | +$331K | ﹤0.01% | 1163 |
|
2016
Q4 | – | Sell |
-4,818
| Closed | -$326K | – | 1634 |
|
2016
Q3 | $326K | Buy |
+4,818
| New | +$326K | ﹤0.01% | 1242 |
|
2016
Q2 | – | Sell |
-4,896
| Closed | -$307K | – | 1619 |
|
2016
Q1 | $307K | Sell |
4,896
-3,187
| -39% | -$200K | ﹤0.01% | 1258 |
|
2015
Q4 | $761K | Buy |
8,083
+2,174
| +37% | +$205K | 0.01% | 907 |
|
2015
Q3 | $475K | Sell |
5,909
-3,625
| -38% | -$291K | ﹤0.01% | 1084 |
|
2015
Q2 | $1.14M | Sell |
9,534
-379
| -4% | -$45.4K | 0.01% | 832 |
|
2015
Q1 | $1.04M | Sell |
9,913
-13
| -0.1% | -$1.36K | 0.01% | 853 |
|
2014
Q4 | $962K | Sell |
9,926
-2,169
| -18% | -$210K | 0.01% | 876 |
|
2014
Q3 | $945K | Buy |
+12,095
| New | +$945K | 0.01% | 915 |
|